| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Assessing bleeding risk in patients taking anticoagulants
|
Shoeb, Marwa
|
|
2013
|
35 |
3 |
p. 312-319
|
artikel
|
| 2 |
Bench to bedside: new developments in our understanding of the pathophysiology of thrombosis
|
Key, Nigel S.
|
|
2013
|
35 |
3 |
p. 342-345
|
artikel
|
| 3 |
Frequency of monitoring, non-adherence, and other topics dear to an anticoagulation clinic provider
|
Clark, Nathan P.
|
|
2013
|
35 |
3 |
p. 320-324
|
artikel
|
| 4 |
Impact of target-specific oral anticoagulants on transitions of care and outpatient care models
|
Wittkowsky, Ann K.
|
|
2013
|
35 |
3 |
p. 304-311
|
artikel
|
| 5 |
Medical prophylaxis: the value of an “opt in” policy
|
Crowther, Mark A.
|
|
2013
|
35 |
3 |
p. 368-370
|
artikel
|
| 6 |
Monitoring target specific anticoagulants
|
Konkle, Barbara A.
|
|
2013
|
35 |
3 |
p. 387-390
|
artikel
|
| 7 |
Pathophysiology and management of thrombosis in cancer: 150 years of progress
|
Soff, Gerald A.
|
|
2013
|
35 |
3 |
p. 346-351
|
artikel
|
| 8 |
Patients with stable, therapeutic INR values should remain on warfarin
|
Garcia, David A.
|
|
2013
|
35 |
3 |
p. 336-338
|
artikel
|
| 9 |
Point-of-care patient self-monitoring of oral vitamin K antagonist therapy
|
Ansell, Jack
|
|
2013
|
35 |
3 |
p. 339-341
|
artikel
|
| 10 |
Prevention of VTE in patients having major orthopedic surgery
|
Francis, Charles W.
|
|
2013
|
35 |
3 |
p. 359-367
|
artikel
|
| 11 |
Proceedings of the 12th national conference on anticoagulant therapy
|
Garcia, David A.
|
|
2013
|
35 |
3 |
p. 303
|
artikel
|
| 12 |
Rationale supporting an “opt-out” policy for pharmacological venous thromboembolism prophylaxis in hospitalized medical patients
|
Goldhaber, Samuel Z.
|
|
2013
|
35 |
3 |
p. 371-374
|
artikel
|
| 13 |
Research Abstracts: 12th National Conference on Anticoagulant Therapy
|
|
|
|
35 |
3 |
p. 399-417
|
artikel
|
| 14 |
Research Abstracts: 12th National Conference on Anticoagulant Therapy
|
|
|
2013
|
35 |
3 |
p. 399-417
|
artikel
|
| 15 |
Reversal of novel oral anticoagulants in patients with major bleeding
|
Siegal, Deborah M.
|
|
2013
|
35 |
3 |
p. 391-398
|
artikel
|
| 16 |
Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know
|
Naik, Rakhi P.
|
|
2013
|
35 |
3 |
p. 352-358
|
artikel
|
| 17 |
The future of inpatient anticoagulation management
|
Burnett, Allison E.
|
|
2013
|
35 |
3 |
p. 375-386
|
artikel
|
| 18 |
Top practice-changing articles over the last two years
|
Kaatz, Scott
|
|
2013
|
35 |
3 |
p. 325-332
|
artikel
|
| 19 |
Vitamin K antagonists and time in the therapeutic range: implications, challenges, and strategies for improvement
|
Hylek, Elaine M.
|
|
2013
|
35 |
3 |
p. 333-335
|
artikel
|
Tijdschrift beschrijving